From a small photonics lab to 5,000+ clinics worldwide — every chapter of our story is built on one promise: devices that clinicians can trust with their patients.
← Back to AboutDerma Rays was born from a single conviction — that precision engineering and clinical science could transform aesthetic medicine. A small team of photonics engineers and dermatologists set out to build what the industry lacked: devices that actually worked.
Our proprietary dual-wavelength laser technology received its first patent. This breakthrough set a new standard in hair reduction precision and launched Derma Rays into the global spotlight.
We expanded into 20 countries, forming R&D partnerships with leading dermatology institutes. Our devices began serving clinics across Asia, Europe, and the Middle East.
The SupraTitan platform cleared FDA and CE certification — a milestone that validated our uncompromising approach to safety and clinical efficacy.
We launched the industry's first AI-guided treatment protocol engine. Real-time skin adaptation in under 2ms. Derma Rays became more than a device company — we became a technology company.
Today, 5,000+ clinic partners across 50+ countries trust Derma Rays. 47 patents. 200+ distributors. 15 years of relentless R&D — and we are just getting started.